BIOS Capital Management, LP
Fort Worth, TX · CIK 1813845 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2019 · partnership
- Assets managed$250.9m
- Staff8 · 6 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds24 · $250.9m gross assets
- Form ADV · 2026-03-30SEC adviser record
- Kindventure
- Others nearbyFort Worth, TX, Woodland Park, CO
As an employer
- Offices in1 country
- Private fundsventure capital 24
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Fort Worth, TX (main office)United States | about 5 |
| Woodland Park, COUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$41.7m
reported value
-21.2% vs Q1 2026
6positions
100.0%in top 10
0 new
1 added
2 reduced
0 sold out
vs Q1 2026
This report includes the holdings of 1 other manager that shares the investment decisions:
- Steelhead Capital Management, LLC – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ACTUATE THERAPEUTICS INC ACTU | $15.4m36.90% | Unchanged |
| OPUS GENETICS INC IRD | $15.1m36.33% | Unchanged |
| COGNITION THERAPEUTICS INC CGTX | $6.9m16.56% | Unchanged |
| REIN THERAPEUTICS INC RNTX | $3.1m7.44% | Added +1.0m |
| LANTERN PHARMA INC LTRN | $1.0m2.50% | Reduced -615.0k |
| IN8BIO INC INAB | $114.1k0.27% | Reduced -86.8k |